Cargando…
Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
Autores principales: | Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959703/ http://dx.doi.org/10.1097/01.GOX.0000533905.72280.11 |
Ejemplares similares
-
Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
por: Swearingen, Bruce J., et al.
Publicado: (2019) -
Abstract 48: A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using A Single Dose of AMD3100 for Stem Cell Mobilization
por: Swearingen, Bruce J., et al.
Publicado: (2017) -
Abstract 55: Discrepancies In Cellular Composition And Gene Expression In Long Acellular Allografts
por: Pan, Deng, et al.
Publicado: (2018) -
Abstract 52: Local Fk506 Implant Technology In Vca - Successful Bridge To Delayed Mixed Chimerism Protocol
por: Lellouch, Alexandre G., et al.
Publicado: (2020) -
Abstract 51: Tolerance Induction Protocol For VCA Across Full Mismatch Barriers In MHC-Defined Miniature Swine
por: Andrews, Alec R., et al.
Publicado: (2020)